Abstract Active ingredients of sunscreens, or UV filters, have increased in use because public awareness of sun safety has risen. In addition to this intentional use, unintentional exposures to UV filters also occur through application of personal care products, where the filters are incorporated into the product. There are 2 main types of UV filters: organic (chemical) filters and the 2 inorganic (mineral) filters, titanium dioxide and zinc oxide. Both allergic contact dermatitis (ACD) and photoallergic contact dermatitis (PACD) have been caused by organic filters; oxybenzone (benzophenone-3) is the most frequently reported contact and photocontact allergen compared with all other UV filters. There are no reports of ACD or PACD to the inorganic (physical) UV filters. Here, we review the categories of sunscreens available, currently marketed UV filters, and their corresponding ACD and PACD.
Get full access to this article
View all access options for this article.
References
1.
HeurungAR, RajuSI, WarshawEM. Adverse reactions to sunscreen agents: epidemiology, responsible irritants and allergens, clinical characteristics, and management. Dermatitis, 2014; 25(6):289–326.
2.
DupontE, GomezJ, BilodeauD. Beyond UV radiation: a skin under challenge. Int J Cosmet Sci, 2013; 35(3):224–232.
3.
WongT, OrtonD. Sunscreen allergy and its investigation. Clin Dermatol, 2011; 29(3):306–310.
4.
LodénM, BeitnerH, GonzalezH, et al. Sunscreen use: controversies, challenges and regulatory aspects. Br J Dermatol, 2011; 165(2):255–262.
5.
LyonsAB, TrullasC, KohliI, et al. Photoprotection beyond ultraviolet radiation: a review of tinted sunscreens. J Am Acad Dermatol, 2021; 84(5):1393–1397.
6.
DonaldsonMR, ColdironBM. No end in sight: the skin cancer epidemic continues. Semin Cutan Med Surg, 2011; 30(1):3–5.
7.
WuS, HanJ, LadenF, et al. Long-term ultraviolet flux, other potential risk factors, and skin cancer risk: a cohort study. Cancer Epidemiol Biomarkers Prev, 2014; 23(6):1080–1089.
8.
SchneiderSL, LimHW. A review of inorganic UV filters zinc oxide and titanium dioxide. Photodermatol Photoimmunol Photomed, 2019; 35(6):442–446.
9.
OralD, YirunA, ErkekogluP. Safety concerns of organic ultraviolet filters: special focus on endocrine-disrupting properties. J Environ Pathol Toxicol Oncol, 2020; 39(3):201–212.
10.
GonzálezE, GonzálezS. Drug photosensitivity, idiopathic photodermatoses, and sunscreens. J Am Acad Dermatol, 1996; 35(6):871–885.
11.
Castanedo-CazaresJP, Hernandez-BlancoD, Carlos-OrtegaB, et al. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial. Photodermatol Photoimmunol Photomed, 2014; 30(1):35–42.
12.
BoukariF, JourdanE, FontasE, et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial. J Am Acad Dermatol, 2015; 72(1):189–190.e1.
13.
Department of Health and Human Services. Sunscreen drug products for over-the-counter human use; final monograph. 64 Federal Register 27666Y27693, 1999. Codified at 21 CFR § 310, 352, 700, and 740.
14.
Food and Drug Administration (US). Sunscreen drug products for over-the-counter human use. Federal Register, 2019. Federal Register 84FR6204-6275, 2019-03019.
15.
DiNardoJC, DownsCA. Dermatological and environmental toxicological impact of the sunscreen ingredient oxybenzone/benzophenone-3. J Cosmet Dermatol, 2018; 17(1):15–19.
16.
JanjuaNR, KongshojB, AnderssonAM, et al. Sunscreens in human plasma and urine after repeated whole-body topical application. J Eur Acad Dermatol Venereol, 2008; 22(4):456–461.
17.
SchlumpfM, CottonB, ConscienceM, et al. In vitro and in vivo estrogenicity of UV screens. Environ Health Perspect, 2001; 109(3):239–244.
18.
WangSQ, TannerPR, LimHW, et al. The evolution of sunscreen products in the United States—a 12-year cross sectional study. Photochem Photobiol Sci, 2013; 12(1):197–202.
19.
RacovitaAD. Titanium dioxide: structure, impact, and toxicity. Int J Environ Res Public Health, 2022; 19(9):5681.
20.
VollerLM, PolcariIC. Public misperceptions of common sunscreen labeling claims: a survey study from the Minnesota State Fair. J Am Acad Dermatol, 2020; 83(3):908–910.
21.
SabzevariN, QiblawiS, NortonSA, et al. Sunscreens: UV filters to protect us: part 1: changing regulations and choices for optimal sun protection. Int J Womens Dermatol, 2021; 7(1):28–44.
22.
ChaiyabutrC, SukakulT, KumpangsinT, et al. Ultraviolet filters in sunscreens and cosmetic products—a market survey. Contact Dermatitis, 2021; 85(1):58–68.
SchauderS, IppenH. Contact and photocontact sensitivity to sunscreens. Review of a 15-year experience and of the literature. Contact Dermatitis, 1997; 37(5):221–232.
25.
GreenspoonJ, AhluwaliaR, JumaN, et al. Allergic and photoallergic contact dermatitis: a 10-year experience. Dermatitis, 2013; 24(1):29–32.
26.
BrydenAM, MoseleyH, IbbotsonSH, et al. Photopatch testing of 1155 patients: results of the U.K. multicentre photopatch study group. Br J Dermatol, 2006; 155(4):737–747.
27.
European Multicentre Photopatch Test Study (EMCPPTS) Taskforce. A European multicentre photopatch test study. Br J Dermatol, 2012; 166(5):1002–1009.
28.
DarvayA, WhiteIR, RycroftRJ, et al. Photoallergic contact dermatitis is uncommon. Br J Dermatol, 2001; 145(4):597–601.
29.
SzczurkoC, DompmartinA, MichelM, et al. Photocontact allergy to oxybenzone: ten years of experience. Photodermatol Photoimmunol Photomed, 1994; 10(4):144–147.
30.
GonçaloM, RuasE, FigueiredoA, et al. Contact and photocontact sensitivity to sunscreens. Contact Dermatitis, 1995; 33(4):278–280.
31.
TravassosAR, ClaesL, BoeyL, et al. Non-fragrance allergens in specific cosmetic products. Contact Dermatitis, 2011; 65(5):276–285.
32.
SchauderS, IppenH. Photoallergic and allergic contact dermatitis from dibenzoylmethanes. Photodermatol, 1986; 3(3):140–147.
33.
Subiabre-FerrerD, Esteve-MartínezA, Blasco-EncinasR, et al. European photopatch test baseline series: a 3-year experience. Contact Dermatitis, 2019; 80(1):5–8.
34.
DeLeoVA, SuarezSM, MasoMJ. Photoallergic contact dermatitis. Results of photopatch testing in New York, 1985 to 1990. Arch Dermatol, 1992; 128(11):1513–1518.
35.
BilslandD, FergusonJ. Contact allergy to sunscreen chemicals in photosensitivity dermatitis/actinic reticuloid syndrome (PD/AR) and polymorphic light eruption (PLE). Contact Dermatitis, 1993; 29(2):70–73.
36.
EnglishJS, WhiteIR, CroninE. Sensitivity to sunscreens. Contact Dermatitis, 1987; 17(3):159–162.
37.
CrouchRB, FoleyPA, BakerCS. The results of photopatch testing 172 patients to sunscreening agents at the photobiology clinic, St Vincent's Hospital, Melbourne. Australas J Dermatol, 2002; 43(1):74.
38.
CookN, FreemanS. Report of 19 cases of photoallergic contact dermatitis to sunscreens seen at the Skin and Cancer Foundation. Australas J Dermatol, 2001; 42(4):257–259.
39.
Avenel-AudranM, DutartreH, GoossensA, et al. Octocrylene, an emerging photoallergen. Arch Dermatol, 2010; 146(7):753–757.
40.
LeniqueP, MachetL, VaillantL, et al. Contact and photocontact allergy to oxybenzone. Contact Dermatitis, 1992; 26(3):177–181.
41.
de GrootAC, WeylandJW. Contact allergy to butyl methoxydibenzoylmethane. Contact Dermatitis, 1987; 16(5):278.
42.
GoldermannR, VardarmanE, NeumannN, et al. Contact dermatitis from UV-A and UV-B filters in a patient with erythropoietic protoporphyria. Contact Dermatitis, 1993; 28(5):300–301.
43.
CroweMJ, BanksSL, GuinJD. Photoallergic and allergic contact dermatitis to butyl-methoxydibenzoylmethane. Am J Contact Dermat, 1992; 3:33–34.
BarrientosN, AbajoP, de CeladaRA, et al. Allergic contact dermatitis caused by phenylbenzimidazole sulfonic acid included in a sunscreen. Contact Dermatitis, 2019; 81(2):151–152.
48.
HughesTM, StoneNM. Benzophenone 4: an emerging allergen in cosmetics and toiletries?Contact Dermatitis, 2007; 56(3):153–156.
49.
RodríguezE, ValbuenaMC, ReyM, et al. Causal agents of photoallergic contact dermatitis diagnosed in the national institute of dermatology of Colombia. Photodermatol Photoimmunol Photomed, 2006; 22(4):189–192.
50.
ThuneP, JansénC, WennerstenG, et al. The Scandinavian multicenter photopatch study 1980–1985: final report. Photodermatol, 1988; 5(6):261–269.
ScalfLA, DavisMD, RohlingerAL, et al. Photopatch testing of 182 patients: a 6-year experience at the Mayo Clinic. Dermatitis, 2009; 20(1):44–52.
53.
MortzCG, ThormannH, GoossensA, et al. Allergic contact dermatitis from ethylhexyl salicylate and other salicylates. Dermatitis, 2010; 21(2):E7–E10.
54.
SinghM, BeckMH. Octyl salicylate: a new contact sensitivity. Contact Dermatitis, 2007; 56(1):48.
55.
ShawDW. Allergic contact dermatitis from octisalate and cis-3-hexenyl salicylate. Dermatitis, 2006; 17(3):152–155.
56.
DensAC, GoossensA, DarcisJ, et al. Allergic contact dermatitis caused by ethylhexyl salicylate with possible cross-reactivity with benzyl salicylate. Contact Dermatitis, 2019; 81(4):317–318.
57.
KarlssonI, Vanden BroeckeK, MårtenssonJ, et al. Clinical and experimental studies of octocrylene's allergenic potency. Contact Dermatitis, 2011; 64(6):343–352.
58.
MadanV, BeckMH. Contact allergy to octocrylene in sunscreen with recurrence from passive transfer of a cosmetic. Contact Dermatitis, 2005; 53(4):241–242.
DumonD, DekeuleneerV, TennstedtD, et al. Allergic contact dermatitis caused by octocrylene in a young child. Contact Dermatitis, 2012; 67(4):240–242.
61.
O'ConnellM, KirkS, WilkinsonMS. Allergic contact dermatitis caused by Tinosorb® M. Contact Dermatitis, 2011; 65(1):48–49.
62.
HaylettAK, ChiangYZ, NieZ, et al. Sunscreen photopatch testing: a series of 157 children. Br J Dermatol, 2014; 171(2):370–375.
63.
SchramSE, GlesneLA, WarshawEM. Allergic contact cheilitis from benzophenone-3 in lip balm and fragrance/flavorings. Dermatitis, 2007; 18(4):221–224.
64.
BeleznayK, de GannesG, KaliaS. Analysis of the prevalence of allergic contact dermatitis to sunscreen: a cohort study. J Cutan Med Surg, 2014; 18(1):15–19.
65.
JourneF, MargueryMC, RakotondrazafyJ, et al. Sunscreen sensitization: a 5-year study. Acta Derm Venereol, 1999; 79(3):211–213.
66.
ChaiyabutrC, SukakulT, LimphokaP, et al. Photopatch testing in a tropical country, Thailand: 20 years' experience. Photodermatol Photoimmunol Photomed, 2021; 37(1):28–33.
67.
BakkumRS, HeuleF. Results of photopatch testing in Rotterdam during a 10-year period. Br J Dermatol, 2002; 146(2):275–279.
68.
DevleeschouwerV, RoelandtsR, GarmynM, et al. Allergic and photoallergic contact dermatitis from ketoprofen: results of (photo) patch testing and follow-up of 42 patients. Contact Dermatitis, 2008; 58(3):159–166.
69.
BerneB, RosAM. 7 Years experience of photopatch testing with sunscreen allergens in Sweden. Contact Dermatitis, 1998; 38(2):61–64.
70.
RademakerM. Occupational contact dermatitis among New Zealand farmers. Australas J Dermatol, 1998; 39(3):164–167.
71.
FischerT, BergströmK. Evaluation of customers' complaints about sunscreen cosmetics sold by the Swedish pharmaceutical company. Contact Dermatitis, 1991; 25(5):319–322.
NedorostST. Facial erythema as a result of benzophenone allergy. J Am Acad Dermatol, 2003; 49(suppl 5):S259–S261.
75.
Kiec-SwierczynskaM, KreciszB, Swierczynska-MachuraD. Photoallergic and allergic reaction to 2-hydroxy-4-methoxybenzophenone (sunscreen) and allergy to cetyl alcohol in cosmetic cream. Contact Dermatitis, 2005; 53(3):170–171.
76.
LandersM, LawS, StorrsFJ. Contact urticaria, allergic contact dermatitis, and photoallergic contact dermatitis from oxybenzone. Am J Contact Dermat, 2003; 14(1):33–34.
77.
TorresV, CorreiaT. Contact and photocontact allergy to oxybenzone and mexenone. Contact Dermatitis, 1991; 25(2):126–127.
78.
RussoJP, IpiñaA, PalazzoloJF, et al. Photoallergic contact dermatitis to sunscreens containing oxybenzone in La Plata, Argentina. Actas Dermosifiliogr (Engl Ed), 2018; 109(6):521–528.
79.
FotiadesJ, SoterNA, LimHW. Results of evaluation of 203 patients for photosensitivity in a 7.3-year period. J Am Acad Dermatol, 1995; 33(4):597–602.
80.
ThuneP. Contact and photocontact allergy to sunscreens. Photodermatol, 1984; 1(1):5–9.
AlankoK, JolankiR, EstlanderT, et al. Occupational allergic contact dermatitis from benzophenone-4 in hair-care products. Contact Dermatitis, 2001; 44(3):188.
83.
CaruanaDM, McPhersonT, CooperS. Allergic contact dermatitis caused by benzophenone-4 in a printer. Contact Dermatitis, 2011; 64(3):183–184.
84.
RamsayDL, CohenHJ, BaerRL. Allergic reaction to benzophenone. Simultaneous occurrence of urticarial and contact sensitivities. Arch Dermatol, 1972; 105(6):906–908.
85.
WahieS, LloydJJ, FarrPM. Positive photocontact responses are not elicited to sunscreen ingredients exposed to UVA prior to application onto the skin. Contact Dermatitis, 2007; 57(4):273–275.
86.
CardosoJC, CanelasMM, GonçaloM, et al. Photopatch testing with an extended series of photoallergens: a 5-year study. Contact Dermatitis, 2009; 60(6):325–329.
87.
BuckleyDA, WayteJ, O'SullivanD, et al. Duration of response to UVA irradiation after application of a known photoallergen. Contact Dermatitis, 1995; 33(2):138–139.
88.
SchmidtT, RingJ, AbeckD. Photoallergic contact dermatitis due to combined UVB (4-methylbenzylidene camphor/octyl methoxycinnamate) and UVA (benzophenone-3/butyl methoxydibenzoylmethane) absorber sensitization. Dermatology, 1998; 196(3):354–357.
MotleyRJ, ReynoldsAJ. Photocontact dermatitis due to isopropyl and butyl methoxy dibenzoylmethanes (Eusolex 8020 and Parsol 1789). Contact Dermatitis, 1989; 21(2):109–110.
91.
StittWZ, ScottGA, MartinRE, et al. Multiple chemical sensitivities, including iatrogenic allergic contact dermatitis, in a patient with chronic actinic dermatitis: implications for management. Am J Contact Dermat, 1996; 7(3):166–170.
92.
SommerS, WilkinsonSM, EnglishJS, et al. Photoallergic contact dermatitis from the sunscreen octyl triazone. Contact Dermatitis, 2002; 46(5):304–305.
93.
CollarisEJ, FrankJ. Photoallergic contact dermatitis caused by ultraviolet filters in different sunscreens. Int J Dermatol, 2008; 47(suppl 1):35–37.
94.
BennàssarA, GrimaltR, RomagueraC, et al. Two cases of photocontact allergy to the new sun filter octocrylene. Dermatol Online J, 2009; 15(12):14.
95.
PigattoPD, LegoriA, BigardiAS, et al. Gruppo Italiano Ricerca Dermatiti da Contatto ed Ambientali Italian Multicenter Study of Allergic Contact Photodermatitis: epidemiological aspects. Am J Contact Dermat, 1996; 7(3):158–163.
96.
LeowYH, WongWK, NgSK, et al. 2 Years experience of photopatch testing in Singapore. Contact Dermatitis, 1994; 31(3):181–182.
KalimoK, FagerlundVL, JansénCT. Concomitant photocontact allergy to a benzophenone derivative and a sunscreen preservative, 6-acetoxy-2,4,-dimethyl-m-dioxane. Photodermatol, 1984; 1(6):315–317.
99.
MenzJ, MullerSA, ConnollySM. Photopatch testing: a six-year experience. J Am Acad Dermatol, 1988; 18(5 Pt 1):1044–1047.
MirallesJC, EscuderoAI, CarbonellA, et al. Allergic contact dermatitis from ethylhexyl salicylate. J Investig Allergol Clin Immunol, 2015; 25(1):66–67.
102.
Carrotte-LefebvreI, BonnevalleA, SegardM, et al. Contact allergy to octocrylene. Contact Dermatitis, 2003; 48(1):46–47.
103.
ChuahSY, LeowYH, GoonAT, et al. Photopatch testing in Asians: a 5-year experience in Singapore. Photodermatol Photoimmunol Photomed, 2013; 29(3):116–120.
104.
García CastroR, Velasco TiradoV, Alonso SardónM, et al. Standard photopatch test battery? Proposal based on current epidemiology and experience in our skin allergy unit. Photodermatol Photoimmunol Photomed, 2021; 37(5):449–453.
105.
KnoblerE, AlmeidaL, RuzkowskiAM, et al. Photoallergy to benzophenone. Arch Dermatol, 1989; 125(6):801–804.
106.
VictorFC, CohenDE, SoterNA. A 20-year analysis of previous and emerging allergens that elicit photoallergic contact dermatitis. J Am Acad Dermatol, 2010; 62(4):605–610.
107.
SilvaR, AlmeidaLM, BrandãoFM. Photoallergy to oxybenzone in cosmetic creams. Contact Dermatitis, 1995; 32(3):176.
108.
KimY, PatelDC, GreigD, et al. Photopatch testing in New Zealand: a 12-year retrospective review. Dermatitis, 2021; 32(1):53–56.
109.
ShawT, SimpsonB, WilsonB, et al. True photoallergy to sunscreens is rare despite popular belief. Dermatitis, 2010; 21(4):185–198.
LanganSM, CollinsP. Photocontact allergy to oxybenzone and contact allergy to lignocaine and prilocaine. Contact Dermatitis, 2006; 54(3):173–174.
112.
ZhangXM, NakagawaM, KawaiK, et al. Erythema-multiforme–like eruption following photoallergic contact dermatitis from oxybenzone. Contact Dermatitis, 1998; 38(1):43–44.
113.
HornHM, HumphreysF, AldridgeRD. Contact dermatitis and prolonged photosensitivity induced by ketoprofen and associated with sensitivity to benzophenone-3. Contact Dermatitis, 1998; 38(6):353–354.
PelusoAM, BardazziF, TostiA. Photocontact dermatitis due to Eusolex 4360. Contact Dermatitis, 1991; 25(1):65–66.
116.
GasparLR, TharmannJ, Maia CamposPM, et al. Skin phototoxicity of cosmetic formulations containing photounstable and photostable UV-filters and vitamin A palmitate. Toxicol In Vitro, 2013; 27(1):418–425.
117.
RohJ, ChengH. Ultraviolet filter, fragrance and preservative allergens in New Zealand sunscreens. Australas J Dermatol, 2022; 63(1):e21–e25.
118.
WarshawEM, WangMZ, MaibachHI, et al. Patch test reactions associated with sunscreen products and the importance of testing to an expanded series: retrospective analysis of North American Contact Dermatitis Group data, 2001 to 2010. Dermatitis, 2013; 24(4):176–182.
119.
SchemanA, JacobS, KattaR, et al. Part 4 of a 4-part series miscellaneous products: trends and alternatives in deodorants, antiperspirants, sunblocks, shaving products, powders, and wipes: data from the American Contact Alternatives Group. J Clin Aesthet Dermatol, 2011; 4(10):35–39.
120.
KeyesE, WerthVP, BrodB. Potential allergenicity of commonly sold high SPF broad spectrum sunscreens in the United States: from the perspective of patients with autoimmune skin disease. Int J Womens Dermatol, 2019; 5(4):227–232.
121.
UterW, GonçaloM, YazarK, et al. Coupled exposure to ingredients of cosmetic products: III. Ultraviolet filters. Contact Dermatitis, 2014; 71(3):162–169.
122.
BerardescaE, ZuberbierT, Sanchez VieraM, et al. Review of the safety of octocrylene used as an ultraviolet filter in cosmetics. J Eur Acad Dermatol Venereol, 2019; 33(suppl 7):25–33.
123.
Gunia-KrzyżakA, SłoczyńskaK, PopiółJ, et al. Cinnamic acid derivatives in cosmetics: current use and future prospects. Int J Cosmet Sci, 2018; 40(4):356–366.
124.
TawfikME, AtwaterAR. Anaphylactoid reaction to benzophenones, with recurrence during patch testing. Contact Dermatitis, 2019; 81(4):303–304.
125.
ScheuerE, WarshawE. Sunscreen allergy: a review of epidemiology, clinical characteristics, and responsible allergens. Dermatitis, 2006; 17(1):3–11.
126.
SchemanA, TeR. Contact allergy to salicylates and cross-reactions. Dermatitis, 2017; 28(4):291.
127.
PanicoA, SerioF, BagordoF, et al. Skin safety and health prevention: an overview of chemicals in cosmetic products. J Prev Med Hyg, 2019; 60(1):E50–E57.
